Monoclonal antibodies--immunotherapy for the critically ill

Area of Science:

• Immunology
• Biotechnology
• Critical Care Medicine

Background:

• Monoclonal antibodies (mAbs) have significantly advanced medical research and diagnostics.
• Development includes murine, human, and humanized forms.
• Current key applications are in transplantation and oncology.

Purpose of the Study:

• To explore the emerging therapeutic potential of monoclonal antibodies (mAbs) in critical care.
• To review the application of mAbs in managing critically ill patients.

Main Methods:

• Review of existing literature and clinical trials on mAb applications.
• Analysis of experimental data and preliminary clinical findings.

Main Results:

• Monoclonal antibodies (mAbs) show promise as a new therapeutic strategy for the critically ill.
• Antibodies targeting bacteria, cytokines, and neutrophil adhesion molecules are being investigated for conditions like septic shock, inflammatory diseases, and ischemia/reperfusion injury.
• Potential efficacy in asthma, pulmonary fibrosis, meningitis, and cerebral malaria is also suggested.

Conclusions:

• Monoclonal antibodies (mAbs) represent an exciting prospect for intensive care medicine.
• Further clinical studies are essential to define the definitive role of mAbs in managing critically ill patients.